If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,014.00    95.00 (4.95%)
Bid:
2,006.00
Ask:
2,010.00
Spread: 4.00 (0.199%)
Market Cap: £3.38b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Update on Catalyst Technologies sale

23 Feb 2026 07:00

RNS Number : 9927T
Johnson Matthey PLC
23 February 2026
 

23rd February 2026

 

Johnson Matthey Plc

(the Company)

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Transaction update

On 22nd May 2025, Johnson Matthey Plc ("JM") and Honeywell International, Inc. ("Honeywell") announced an agreement to sell JM's Catalyst Technologies business ("CT") to Honeywell (the "Transaction").

JM and Honeywell have agreed to extend the long stop date for satisfaction of the closing conditions (the "Long Stop Date") from 21st February to 21st July 2026. In the event that the only remaining antitrust approval condition is not satisfied by the Long Stop Date, the Long Stop Date may be further extended to 21st August 2026, if certain conditions are met. JM and Honeywell expect to complete the Transaction by the end of August 2026.

In agreeing to extend the Long Stop Date, JM and Honeywell have also agreed to amend the financial terms of the Transaction to reflect CT's business performance during 2025/26, which includes the deferral of key sustainable solutions licensing projects and reduced profitability from the supply of catalysts due to the challenging market environment. Accordingly, JM has agreed to sell the CT business to Honeywell for an enterprise value of £1,325 million on a cash and debt-free basis.

Consequently, JM now expects to return c.£1,000 million of net sale proceeds to its shareholders following completion of the Transaction, comprising £800 million through a special dividend with share consolidation, and £200 million through an on-market share buyback programme.

JM continues to make good progress on the implementation of its new cash-focused business model and is on track to deliver 2025/26 performance in line with guidance. This includes group underlying operating profit growth at the higher end of a mid single digit percentage range¹, and positive free cash flow that is materially higher than last year².

The person responsible for the release of this announcement is Simon Price, General Counsel and Company Secretary of JM.

ENDS

 

Enquiries: 

Investor Relations

 

 

Louise Curran

Head of Investor Relations

+44 20 7269 8235

Media

Sinead Keller

Guy Bates 

Group External Relations Director

Kekst CNC

+44 20 7269 8218

+44 7581 056 415

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

Notes:

1.

Underlying operating profit is on a pro forma basis excluding CT and Value Businesses, and at constant precious metal prices and constant currency. 

2.

Free cash flow defined as net cash flow from operating activities (excluding disposal related costs) after net interest paid, net purchases of non-current assets and investments and the principal elements of lease payments, adjusted to reflect the classification of Catalyst Technologies as a discontinued operation. 2024/25: £64 million inflow.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURXLLLLQLLEBBF
Date   Source Headline
19th Nov 20207:00 amRNSJohnson Matthey half year results 30 Sept 2020
13th Nov 20204:45 pmRNSHolding(s) in Company
22nd Oct 20204:49 pmRNSDirector/PDMR Shareholding
29th Sep 20204:52 pmRNSDirector/PDMR Shareholding
21st Sep 20204:08 pmRNSDirector/PDMR Shareholding
18th Sep 20204:21 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSJohnson Matthey: Hydrogen Seminar
21st Aug 20209:05 amRNSDirector/PDMR Shareholding
11th Aug 202010:12 amRNSDoug Webb - New Directorship
6th Aug 20204:19 pmRNSDirector/PDMR Shareholding
6th Aug 20204:11 pmRNSDirector/PDMR Shareholding
5th Aug 20204:25 pmRNSDirector/PDMR Shareholding
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 20204:04 pmRNSDirector/PDMR Shareholding
30th Jul 20202:45 pmRNSDirector Declaration
23rd Jul 20203:25 pmRNSResult of AGM
23rd Jul 20207:00 amRNSJohnson Matthey Q1 AGM trading update
17th Jul 20201:31 pmRNSDirector/PDMR Shareholding
14th Jul 202012:18 pmRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSAnna Manz, CFO, to leave JM and join LSEG
23rd Jun 20207:00 amRNSAnnual Financial Report
19th Jun 20203:14 pmRNSDirector/PDMR Shareholding
16th Jun 20205:13 pmRNSDirector/PDMR Shareholding
16th Jun 20209:00 amRNSCompany Secretary Change
11th Jun 20207:00 amRNSPreliminary results for year ended 31st March 2020
4th Jun 20204:35 pmRNSDirector/PDMR Shareholding
21st May 20204:08 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSJohnson Matthey revised date for full year results
28th Apr 20203:45 pmRNSRights attaching to ordinary shares
22nd Apr 20207:00 amRNSJM and COVID-19: supporting our stakeholders
16th Apr 20204:56 pmRNSDirector/PDMR Shareholding
2nd Apr 202010:31 amRNSJane Griffiths - New Directorship
1st Apr 20207:00 amRNSCompany Secretary Change
30th Mar 20207:00 amRNSJohnson Matthey pre-close trading statement
19th Mar 20203:11 pmRNSDirector/PDMR Shareholding
25th Feb 202011:04 amRNSDirector/PDMR Shareholding
20th Feb 20203:35 pmRNSDirector/PDMR Shareholding
6th Feb 20205:33 pmRNSDirector/PDMR Shareholding
6th Feb 20203:52 pmRNSDirector/PDMR Shareholding
6th Feb 20203:41 pmRNSDirector/PDMR Shareholding
6th Feb 20203:29 pmRNSDirector/PDMR Shareholding
4th Feb 20207:30 amRNSJohn O'Higgins - New Directorship
17th Jan 202010:09 amRNSDirector/PDMR Shareholding
19th Dec 20194:31 pmRNSDirector/PDMR Shareholding
26th Nov 20195:06 pmRNSHolding(s) in Company
26th Nov 20195:01 pmRNSDirector/PDMR Shareholding
26th Nov 20194:53 pmRNSDirector/PDMR Shareholding
26th Nov 20194:41 pmRNSDirector/PDMR Shareholding
25th Nov 201911:56 amRNSDirector/PDMR Shareholding
25th Nov 201910:18 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.